ISMP Medication Safety Self-Assessment for High-Alert Medications
The Institute for Safe Medication Practices (ISMP) has released a self-assessment tool that aims to help organizations assess the safety of their systems and practices for high-alert medications and to identify opportunities for improvement. High-alert medications are those that bear an increased risk of causing significant harm if they are used in error, ISMP said. Since not all targeted high-alert medications will be used in every facility, the tool allows users to choose one or more high-alert medications to focus the assessment on, ISMP said. The organization said it “strongly” encourages facilities to complete the assessment for every high-alert medication category used, including those in the “general” section of the tool. ISMP also urged facilities to anonymously submit their findings to them, and organizations that do so by December 15, 2017, will receive a weighted score to compare with their peers. ECRI Institute has endorsed the self-assessment.